SPI
16 779,76
|
161,19
|
0,97 %
|
Analysen zu SPI-Werten
13:38 | Givaudan Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
12:32 | ams-OSRAM Buy | Jefferies & Company Inc. | |
12:29 | Givaudan Hold | Deutsche Bank AG | |
12:29 | Roche Sell | Deutsche Bank AG | |
12:04 | Richemont Hold | Deutsche Bank AG | |
11:57 | Givaudan Neutral | UBS AG | |
11:55 | ams-OSRAM Buy | UBS AG | |
11:54 | ams-OSRAM Neutral | JP Morgan Chase & Co. | |
11:04 | Givaudan Overweight | JP Morgan Chase & Co. | |
10:31 | Givaudan Buy | Goldman Sachs Group Inc. | |
07:03 | Givaudan Equal Weight | Barclays Capital | |
22.07.25 | Givaudan Add | Baader Bank | |
22.07.25 | Novartis Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
22.07.25 | Givaudan Neutral | UBS AG | |
22.07.25 | Roche Sell | Deutsche Bank AG | |
22.07.25 | Givaudan Underperform | Jefferies & Company Inc. | |
22.07.25 | Givaudan Overweight | JP Morgan Chase & Co. | |
22.07.25 | Novartis Neutral | UBS AG | |
21.07.25 | Richemont Overweight | JP Morgan Chase & Co. | |
21.07.25 | ABB Sell | Deutsche Bank AG | |
21.07.25 | Roche Underweight | JP Morgan Chase & Co. | |
21.07.25 | Richemont Sector Perform | RBC Capital Markets | |
21.07.25 | Nestlé Equal Weight | Barclays Capital | |
21.07.25 | UBS Overweight | JP Morgan Chase & Co. | |
21.07.25 | Givaudan Overweight | JP Morgan Chase & Co. | |
18.07.25 | Novartis Kaufen | DZ BANK | |
18.07.25 | Swiss Re Neutral | Goldman Sachs Group Inc. | |
18.07.25 | Novartis Neutral | Goldman Sachs Group Inc. | |
18.07.25 | ABB Underweight | Barclays Capital | |
18.07.25 | ABB Sell | Deutsche Bank AG | |
18.07.25 | Novartis Buy | Deutsche Bank AG | |
18.07.25 | Roche Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
18.07.25 | Nestlé Market-Perform | Bernstein Research | |
18.07.25 | ABB Sector Perform | RBC Capital Markets | |
18.07.25 | Novartis Neutral | JP Morgan Chase & Co. | |
17.07.25 | ABB Kaufen | DZ BANK | |
17.07.25 | Novartis Outperform | Bernstein Research | |
17.07.25 | Novartis Hold | Jefferies & Company Inc. | |
17.07.25 | Novartis Neutral | UBS AG | |
17.07.25 | Richemont Buy | UBS AG |